Siemens Healthcare has received the US Food and Drug Administration (FDA) 510(k) clearance for the Biograph mMR, which represents the integration of diagnostic-grade magnetic resonance (MR) and positron emission tomography (PET) into a single-gantry whole-body scanner.
The Biograph mMR features an incorporation of Siemens Healthcare‘s 3T MR technology and Avalanche photodiode solid-state PET detector technology.
It enables simultaneous whole-body acquisition of data from magnetic resonance (MR) and positron emission tomography (PET).
The Biograph mMR allows a combined approach to imaging anatomical, functional and biochemical characteristics of disease.
Potential clinical applications for molecular MR include the early identification and staging of malignancies, therapy planning, and treatment.
Siemens Healthcare claims, with the Biograph mMR, patients can be scanned in as few as 30 minutes for a combined whole-body exam, compared to one hour or more for sequential MR and PET exams.
Additionally, Biograph mMR has a footprint comparable to a standard, high-field MR scanner and can be sited in a typical MR room, eliminating renovation costs for facilities seeking to replace an existing MRI.